Jagsonpal Pharmaceuticals’ buyback of ā¹40.00 crores was approved by the board of directors at the meeting held on March 12, 2026. Jagsonpal Pharmaceuticals’ buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ā¹10 each equity share at a price of ā¹250 per Equity Share and for an aggregate amount not exceeding ā¹40.00 crores from the shareholders. Check out Jagsonpal Pharmaceuticals Buyback 2026 details below:
Jagsonpal Pharmaceuticals Buyback About us
Jagsonpal Pharmaceuticals Ltd is one of the leading pharmaceutical companies in Gurgaon, manufacturing and marketing medicines along with a strong presence in India.
Jagsonpal mainly specialises in gynaecology and orthopaedics, which make up a large share of its business. It is considered a strong player in womenās health, especially in progesterone-based products. The company offers medicines in different forms such as tablets, injections, and syrups.
Further, the company’s production includes both in-house capabilities (Faridabad plant) and loan licensing, with a comprehensive quality management system that tests every batch.
Jagsonpal Pharmaceuticals Buyback History
- N/A
Jagsonpal Pharmaceuticals Buyback 2026 Dates
| Buyback Meeting Date: | March 12, 2026 |
| Buyback Announcement Date: | March 12, 2026 |
| Buyback Record Date: | 2026 |
| Last Date to Buy Shares: | 2026 |
| Buyback Open Date: | 2026 |
| Buyback Close Date: | 2026 |
| Finalization of Buyback Acceptance: | 2026 |
Jagsonpal Pharmaceuticals Buyback 2026 Offer Details
Jagsonpal Pharmaceuticals Buyback of 16,00,000 equity shares at a price of ā¹250 per equity share. The buyback offers not to exceed ā¹40.00 crores of the total buyback offer size.
| Offer Amount: | ā¹40.00 Crores |
| Number of Shares: | 16,00,000 Equity Shares |
| Face Value: | ā¹10 per equity share |
| Buyback Price: | ā¹250 per equity share |
| Listing: | BSE, NSE |
| Buyback Type: | Tender Offer |
| Letter of Offer: | Click Here |
Jagsonpal Pharmaceuticals Buyback 2026 Acceptance Ratio
The investor should buy around 800 shares at a current market price of ā¹183.86 (as of date). The calculation will be ā¹2,00,000 / ā¹250 buyback price = 800 shares.
| Acceptance Ratio | Investment | Shares Buyback | Profit |
| 33% | ā¹1,47,200 | 264 | ā¹48,576 |
| 50% | ā¹1,47,200 | 400 | ā¹73,600 |
| 75% | ā¹1,47,200 | 600 | ā¹1,10,400 |
| 100% | ā¹1,47,200 | 800 | ā¹1,47,200 |
Jagsonpal Pharmaceuticals Financial Report
| ā¹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2023 | ā¹242.45 | ā¹204.18 | ā¹26.72 |
| 2024 | ā¹217.98 | ā¹188.11 | ā¹22.46 |
| 2025 | ā¹276.91 | ā¹226.73 | ā¹55.36 |
How to Participate in Jagsonpal Pharmaceuticals Buyback 2026
The investors are eligible for the buyback scheme who have Jagsonpal Pharmaceuticals Buyback shares in their Demat Account as the Record Date. Eligible Share Holders can participate in the Jagsonpal Pharmaceuticals Buyback 2026 scheme as per the opening form by selling their shares. The payment will be given as per the Jagsonpal Pharmaceuticals Buyback accepted shares by the company under the Jagsonpal Pharmaceuticals Buyback scheme.
Jagsonpal Pharmaceuticals Buyback 2026 Registrar
To be updated soon
Jagsonpal Pharmaceuticals Buyback 2026 Lead Managers
- To be updated soon
Jagsonpal Pharmaceuticals Company Address
Jagsonpal Pharmaceuticals Ltd.
Plot No. 412-415,
Nimal Tower, 3rd Floor, Phase IV
Udyog Vihar Sector 18
Gurgaon, Haryana, 122015
Phone: 0124-4406710
Email: cs@jagsonpal.com
Website: https://www.jagsonpal.com/
